JP2023518161A5 - - Google Patents

Info

Publication number
JP2023518161A5
JP2023518161A5 JP2022549375A JP2022549375A JP2023518161A5 JP 2023518161 A5 JP2023518161 A5 JP 2023518161A5 JP 2022549375 A JP2022549375 A JP 2022549375A JP 2022549375 A JP2022549375 A JP 2022549375A JP 2023518161 A5 JP2023518161 A5 JP 2023518161A5
Authority
JP
Japan
Prior art keywords
atoms
group
conjugate
pharmaceutically acceptable
polymorph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022549375A
Other languages
English (en)
Japanese (ja)
Other versions
JP7787083B2 (ja
JP2023518161A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/056424 external-priority patent/WO2021180969A1/en
Publication of JP2023518161A publication Critical patent/JP2023518161A/ja
Publication of JP2023518161A5 publication Critical patent/JP2023518161A5/ja
Application granted granted Critical
Publication of JP7787083B2 publication Critical patent/JP7787083B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022549375A 2020-03-12 2021-03-12 アルファ-v-ベータ-6-インテグリンをインビボでアドレッシングするための環状ペプチド及びそれらのコンジュゲート Active JP7787083B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20162699.1 2020-03-12
EP20162699 2020-03-12
PCT/EP2021/056424 WO2021180969A1 (en) 2020-03-12 2021-03-12 Cyclic peptides and their conjugates for addressing alpha-v-beta-6 integrin in vivo

Publications (3)

Publication Number Publication Date
JP2023518161A JP2023518161A (ja) 2023-04-28
JP2023518161A5 true JP2023518161A5 (cg-RX-API-DMAC7.html) 2023-10-30
JP7787083B2 JP7787083B2 (ja) 2025-12-16

Family

ID=69810651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549375A Active JP7787083B2 (ja) 2020-03-12 2021-03-12 アルファ-v-ベータ-6-インテグリンをインビボでアドレッシングするための環状ペプチド及びそれらのコンジュゲート

Country Status (11)

Country Link
US (1) US20230173113A1 (cg-RX-API-DMAC7.html)
EP (1) EP4117736A1 (cg-RX-API-DMAC7.html)
JP (1) JP7787083B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220152322A (cg-RX-API-DMAC7.html)
CN (1) CN115297893B (cg-RX-API-DMAC7.html)
AU (1) AU2021233176A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016986A2 (cg-RX-API-DMAC7.html)
CA (1) CA3175061A1 (cg-RX-API-DMAC7.html)
IL (1) IL296081A (cg-RX-API-DMAC7.html)
MX (1) MX2022011287A (cg-RX-API-DMAC7.html)
WO (1) WO2021180969A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021226432A2 (en) * 2020-05-08 2021-11-11 The Regents Of The University Of California Methods of detecting and treating lung damage in respiratory-related viral infections
CN120829485A (zh) * 2024-04-16 2025-10-24 中山医诺维申新药研发有限公司 双重靶向成纤维细胞激活蛋白和整合素亚型的化合物及其制备和应用
WO2026027771A1 (en) 2024-08-02 2026-02-05 Trimt Gmbh Alpha v beta 6-integrin binding cyclopeptides with non-natural amino acids, and conjugates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19933173A1 (de) * 1999-07-15 2001-01-18 Merck Patent Gmbh Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
WO2009117531A1 (en) 2008-03-18 2009-09-24 Seattle Genetics, Inc. Auristatin drug linker conjugates
EP3107557B1 (en) 2014-02-17 2021-06-09 Seagen Inc. Hydrophilic antibody-drug conjugates
ES2898844T3 (es) * 2015-09-18 2022-03-09 Univ Muenchen Tech Ligandos para integrina alphavbeta6, síntesis y usos de los mismos
CN109563135B (zh) * 2016-06-13 2024-01-23 加利福尼亚大学董事会 α(V)β(6)整合素结合肽及其使用方法
WO2019154842A1 (en) * 2018-02-06 2019-08-15 Klinikum Rechts Der Isar Der Technischen Universität München Compound for intraoperative molecular bioimaging, method of making the same, use thereof in intraoperative molecular bioimaging and surgical method comprising intraoperative molecular bioimaging

Similar Documents

Publication Publication Date Title
JP6997135B2 (ja) Grpr陽性ガンの検出、診断及び治療のためのgrprアンタゴニスト
JP3853354B2 (ja) 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤
CN117563022A (zh) 可用于成像和抗肿瘤治疗的具有可调的药代动力学的三功能构建体
JP7673056B2 (ja) Grprアンタゴニストを放射標識するための方法及びそれらのキット
JP2014524419A (ja) 放射標識された前立腺特異的膜抗原阻害剤
FI81263B (fi) Foerfarande foer maerkning av en maolsoekande biologiskt aktiv molekyl och metalltionein.
CN118647415A (zh) 包含225锕标记的络合物和铋多价螯合剂的药物组合物
JP2004532820A (ja) 標的放射線療法のためのアクチニウム−225錯体および複合体
AU2002306598A1 (en) Actinium-225 complexes and conjugates for targeted radiotherapy
JPH06220079A (ja) レニウム錯体
AU8094791A (en) Technetium-99m complex for examining the renal function
JP2004509967A (ja) 医学及び治療法の適用に使用するための金属錯体
Shah et al. Radiosynthesis and biological evaluation of 99m TcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection
EP1192166B1 (en) Group(vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
JP2003535005A (ja) 過テクネチウム酸塩および過レニウム酸塩の還元剤としてスズイオンを使用するTcおよびReカルボニル錯体の処方
WO2023202730A2 (zh) 放射性伊文思蓝衍生物药物水溶液及其制备方法和用途
JP7854076B2 (ja) 放射性医薬組成物及び方法
KR102269315B1 (ko) 전립선 암의 영상 또는 치료를 위한 동위원소 표지 화합물
JP7608378B2 (ja) 前立腺特異的膜抗原(psma)リガンド及びその使用
JP7299911B2 (ja) 肝臓の画像化用配位子としての新規なdazaキレート剤
JPH05508162A (ja) イソニトリルリガンド含有金属―放射性核種錯化合物
KR101494429B1 (ko) NODAGA 표지 글루코사민-함유 시클로 RGDfK 유도체, 그 제조방법 및 그것을 포함하는 핵의학 영상 조영제 및 암 치료제
CN117563023A (zh) Pd-l1靶向的放射性分子探针及其制备方法和应用
CN115484991A (zh) 用于放射性标记psma结合配体的方法及其试剂盒
WO2006054466A1 (ja) 新規放射性テクネチウム-ビスホスフィノアミン錯体および該錯体を含む放射性画像診断剤